null
SMILES: CC[C@@H](C1=C(O)C[C@@](CCCNC(=O)OCCOCCOCCOCCOCCOC)(CCc2ccccc2)OC1=O)c1cccc(NS(=O)(=O)c2ccc(cn2)C(F)(F)F)c1
InChI Key: InChIKey=NNBCVULMVHXQSK-CBZWEFONSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIV-1 protease (Human immunodeficiency virus) | BDBM468570 (US10806794, Compound mPEG5-OCONH-Tipranavir) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.462 | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Protease inhibitors (PI) are used to treat HIV infection by preventing viral assembly and maturation through the inhibition of HIV-1 protease activit... | US Patent US10806794 (2020) | |||||||||||
More data for this Ligand-Target Pair |